Related Experiment Video
Updated: Feb 28, 2026

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
Centrosomal Protein 70 Is a Mediator of Paclitaxel Sensitivity
Xingjuan Shi1, Yujue Wang2, Xiaoou Sun3
1Key Laboratory of Developmental Genes and Human Disease, Institute of Life Sciences, Southeast University, Nanjing 210096, China. xingjuanshi@seu.edu.cn.
Abstract:
Centrosome aberrations have been implicated in the development and progression of breast cancer. Our previous worked show that centrosomal protein 70 (Cep70) regulates breast cancer growth and metastasis. However, it remains elusive whether Cep70 is implicated in the sensitivity of the anti-microtubule drug paclitaxel in breast cancer. Here we provide evidence that Cep70 is a mediator of paclitaxel sensitivity in breast cancer. Cell proliferation assays show that Cep70 expression correlates with paclitaxel sensitivity in breast cancer cell lines. In addition, paclitaxel sensitivity varies when altering Cep70 expression level. Mechanistic studies reveal that Cep70 interacts with tubulin, and promotes the ability of paclitaxel to stimulate microtubule assembly. These data demonstrate that Cep70 mediates paclitaxel sensitivity in breast cancer.
Insights
Centrosomal protein 70 (Cep70) regulates breast cancer growth and metastasis. This study shows Cep70 mediates paclitaxel sensitivity by interacting with tubulin and promoting microtubule assembly in breast cancer.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Centrosome aberrations are linked to breast cancer development and progression.
- Centrosomal protein 70 (Cep70) was previously shown to regulate breast cancer growth and metastasis.
Purpose of the Study:
- To investigate the role of Cep70 in paclitaxel sensitivity in breast cancer.
- To determine if Cep70 influences the efficacy of anti-microtubule chemotherapy.
Main Methods:
- Cell proliferation assays were used to assess paclitaxel sensitivity.
- Cep70 expression levels were altered to observe effects on drug sensitivity.
- Mechanistic studies involving tubulin interaction and microtubule assembly assays were performed.
Main Results:
- Cep70 expression levels positively correlated with paclitaxel sensitivity in breast cancer cell lines.
- Altering Cep70 expression significantly modulated paclitaxel sensitivity.
- Cep70 was found to interact with tubulin, enhancing paclitaxel-induced microtubule assembly.
Conclusions:
- Cep70 acts as a mediator of paclitaxel sensitivity in breast cancer.
- Cep70's interaction with tubulin and promotion of microtubule assembly are key mechanisms underlying its role in drug response.
Related Concept Videos
Drugs that Stabilize Microtubules
Destabilization of Microtubules
Drugs that Destabilize Microtubules
Microtubule Associated Proteins (MAPs)

